Zkusit zdarma
Repare Therapeutics Inc.

Repare Therapeutics Inc.

RPTX
Cena:
$ 2.65
0.00 (0.00%)
Valuace
70
Růst
63
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Repare Therapeutics (NASDAQ:RPTX) Trading Up 0.8% – What’s Next?

Repare Therapeutics (NASDAQ:RPTX) Trading Up 0.8% – What’s Next?

4:48 20-02-2026

Repare Therapeutics Inc. (NASDAQ: RPTX - Get Free Report)'s stock price rose 0.8% on Thursday. The c...

Repare Shareholders Approve Acquisition by XenoTherapeutics, Inc.

Repare Shareholders Approve Acquisition by XenoTherapeutics, Inc.

16:58 16-01-2026

CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Compa...

Repare Therapeutics (NASDAQ:RPTX) Stock Price Up 0.4% – Here’s Why

Repare Therapeutics (NASDAQ:RPTX) Stock Price Up 0.4% – Here’s Why

2:27 15-01-2026

Repare Therapeutics Inc. (NASDAQ: RPTX - Get Free Report)'s stock price rose 0.4% on Wednesday. The ...

Repare Therapeutics Target of Unusually Large Options Trading (NASDAQ:RPTX)

Repare Therapeutics Target of Unusually Large Options Trading (NASDAQ:RPTX)

1:44 25-12-2025

Repare Therapeutics Inc. (NASDAQ: RPTX - Get Free Report) was the recipient of unusually large optio...

Repare Therapeutics Announces Acquisition of Polθ ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration

Repare Therapeutics Announces Acquisition of Polθ ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration

7:00 24-12-2025

CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Compa...

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—RPTX, CNBN, KMB, and KVUE

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—RPTX, CNBN, KMB, and KVUE

11:18 04-12-2025

NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & ...

Halper Sadeh LLC Encourages RPTX, THS, RMBI Shareholders to Contact the Firm to Discuss Their Rights

Halper Sadeh LLC Encourages RPTX, THS, RMBI Shareholders to Contact the Firm to Discuss Their Rights

18:47 27-11-2025

NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is invest...

Repare Therapeutics Inc. (NASDAQ:RPTX) Receives $3.50 Average PT from Brokerages

Repare Therapeutics Inc. (NASDAQ:RPTX) Receives $3.50 Average PT from Brokerages

3:28 25-11-2025

Repare Therapeutics Inc. (NASDAQ: RPTX - Get Free Report) has received a consensus recommendation of...

Repare Therapeutics Enters into Support and Voting Agreements with Significant Shareholders for Proposed Transaction with XenoTherapeutics, Inc.

Repare Therapeutics Enters into Support and Voting Agreements with Significant Shareholders for Proposed Transaction with XenoTherapeutics, Inc.

17:25 20-11-2025

CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Compa...

Halper Sadeh LLC Encourages RPTX and SEE Shareholders to Contact the Firm to Discuss Their Rights

Halper Sadeh LLC Encourages RPTX and SEE Shareholders to Contact the Firm to Discuss Their Rights

7:44 18-11-2025

Shareholders should contact the firm immediately as there may be limited time to enforce your rights...

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Repare Therapeutics Inc. (NASDAQ: RPTX)

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Repare Therapeutics Inc. (NASDAQ: RPTX)

17:30 17-11-2025

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney  Juan Monteverde with Monteverde ...

Repare Therapeutics Agrees To Acquisition As Board Cites Best Path For Stakeholder Value

Repare Therapeutics Agrees To Acquisition As Board Cites Best Path For Stakeholder Value

10:24 17-11-2025

XenoTherapeutics Inc. and Xeno Acquisition Corp, a non-profit biotechnology company, on Friday agree...

RPTX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Repare Therapeutics Inc. is Fair to Shareholders

RPTX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Repare Therapeutics Inc. is Fair to Shareholders

22:59 14-11-2025

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t...

Shareholder Alert: The Ademi Firm investigates whether Repare Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders

Shareholder Alert: The Ademi Firm investigates whether Repare Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders

19:56 14-11-2025

MILWAUKEE , Nov. 14, 2025 /PRNewswire/ -- The Ademi Firm is investigating Repare (Nasdaq: RPTX) for ...

Repare Therapeutics Inc. (RPTX) Reports Break-Even Earnings for Q3

Repare Therapeutics Inc. (RPTX) Reports Break-Even Earnings for Q3

19:01 14-11-2025

Repare Therapeutics Inc. (RPTX) reported break-even quarterly earnings per share versus the Zacks Co...

Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc.

Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc.

16:44 14-11-2025

CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Compa...

Repare Therapeutics Inc. (RPTX) Reports Q2 Loss, Misses Revenue Estimates

Repare Therapeutics Inc. (RPTX) Reports Q2 Loss, Misses Revenue Estimates

9:10 08-08-2025

Repare Therapeutics Inc. (RPTX) came out with a quarterly loss of $0.39 per share versus the Zacks C...

Repare (RPTX) Q2 Loss Narrows 52%

Repare (RPTX) Q2 Loss Narrows 52%

7:13 08-08-2025

Repare (RPTX) Q2 Loss Narrows 52%...

Repare Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

Repare Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

7:00 08-08-2025

CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Compa...

Repare Therapeutics Enters Exclusive Worldwide Licensing Agreement with Debiopharm for Lunresertib

Repare Therapeutics Enters Exclusive Worldwide Licensing Agreement with Debiopharm for Lunresertib

16:05 15-07-2025

CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Compa...

close

REPARE SHAREHOLDERS APPROVE ACQUISITION BY XENOTHERAPEUTICS, INC.

16-01-2026
CAMBRIDGE, MASS. & MONTREAL--(BUSINESS WIRE)--REPARE THERAPEUTICS INC. (“REPARE” OR THE “COMPA...
Více zde

REPARE THERAPEUTICS ANNOUNCES ACQUISITION OF POLΘ ATPASE INHIBITOR, RP-3467, BY GILEAD SCIENCES FOR UP TO $30 MILLION IN TOTAL CONSIDERATION

24-12-2025
CAMBRIDGE, MASS. & MONTREAL--(BUSINESS WIRE)--REPARE THERAPEUTICS INC. (“REPARE” OR THE “COMPA...
Více zde

BRODSKY & SMITH SHAREHOLDER UPDATE: NOTIFYING INVESTORS OF THE FOLLOWING INVESTIGATIONS: REPARE THERAPEUTICS INC. (NASDAQ – RPTX), AXALTA COATING SYSTEMS LTD. (NYSE – AXTA), BLUE FOUNDRY BANCORP (NASDAQ – BLFY), GOLDEN ENTERTAINMENT, INC (NASDAQ - GDEN)

08-12-2025
BALA CYNWYD, PA., DEC. 08, 2025 (GLOBE NEWSWIRE) -- BRODSKY & SMITH REMINDS INVESTORS OF THE FOLLOWI...
Více zde

$HAREHOLDER ALERT: THE M&A CLASS ACTION FIRM LAUNCHES LEGAL INQUIRY FOR THE MERGER—RPTX, CNBN, KMB, AND KVUE

04-12-2025
NEW YORK, DEC. 04, 2025 (GLOBE NEWSWIRE) -- CLASS ACTION ATTORNEY JUAN MONTEVERDE WITH MONTEVERDE & ...
Více zde

REPARE THERAPEUTICS ENTERS INTO SUPPORT AND VOTING AGREEMENTS WITH SIGNIFICANT SHAREHOLDERS FOR PROPOSED TRANSACTION WITH XENOTHERAPEUTICS, INC.

20-11-2025
CAMBRIDGE, MASS. & MONTREAL--(BUSINESS WIRE)--REPARE THERAPEUTICS INC. (“REPARE” OR THE “COMPA...
Více zde

HALPER SADEH LLC ENCOURAGES RPTX AND SEE SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

18-11-2025
SHAREHOLDERS SHOULD CONTACT THE FIRM IMMEDIATELY AS THERE MAY BE LIMITED TIME TO ENFORCE YOUR RIGHTS...
Více zde

$HAREHOLDER ALERT: THE M&A CLASS ACTION FIRM ANNOUNCES AN INVESTIGATION OF REPARE THERAPEUTICS INC. (NASDAQ: RPTX)

17-11-2025
NEW YORK, NOV. 17, 2025 (GLOBE NEWSWIRE) -- CLASS ACTION ATTORNEY  JUAN MONTEVERDE WITH MONTEVERDE ...
Více zde

RPTX STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE SALE OF REPARE THERAPEUTICS INC. IS FAIR TO SHAREHOLDERS

14-11-2025
NEW YORK--(BUSINESS WIRE)--HALPER SADEH LLC, AN INVESTOR RIGHTS LAW FIRM, IS INVESTIGATING WHETHER T...
Více zde

SHAREHOLDER ALERT: THE ADEMI FIRM INVESTIGATES WHETHER REPARE THERAPEUTICS INC. IS OBTAINING A FAIR PRICE FOR ITS PUBLIC SHAREHOLDERS

14-11-2025
MILWAUKEE , NOV. 14, 2025 /PRNEWSWIRE/ -- THE ADEMI FIRM IS INVESTIGATING REPARE (NASDAQ: RPTX) FOR ...
Více zde

REPARE THERAPEUTICS ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY XENOTHERAPEUTICS, INC.

14-11-2025
CAMBRIDGE, MASS. & MONTREAL--(BUSINESS WIRE)--REPARE THERAPEUTICS INC. (“REPARE” OR THE “COMPA...
Více zde

REPARE THERAPEUTICS TO PRESENT INITIAL DATA FROM PHASE 1 LIONS CLINICAL TRIAL AT 37TH AACR-NCI-EORTC INTERNATIONAL CONFERENCE ON MOLECULAR TARGETS AND CANCER THERAPEUTICS

13-10-2025
CAMBRIDGE, MASS. & MONTREAL--(BUSINESS WIRE)--REPARE THERAPEUTICS INC. (“REPARE” OR THE “COMPA...
Více zde

REPARE THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS

08-08-2025
CAMBRIDGE, MASS. & MONTREAL--(BUSINESS WIRE)--REPARE THERAPEUTICS INC. (“REPARE” OR THE “COMPA...
Více zde

REPARE THERAPEUTICS ENTERS EXCLUSIVE WORLDWIDE LICENSING AGREEMENT WITH DEBIOPHARM FOR LUNRESERTIB

15-07-2025
CAMBRIDGE, MASS. & MONTREAL--(BUSINESS WIRE)--REPARE THERAPEUTICS INC. (“REPARE” OR THE “COMPA...
Více zde

REPARE THERAPEUTICS PROVIDES BUSINESS AND CLINICAL UPDATE AND REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS

13-05-2025
CAMBRIDGE, MASS. & MONTREAL--(BUSINESS WIRE)--REPARE THERAPEUTICS INC. (“REPARE” OR THE “COMPA...
Více zde

REPARE THERAPEUTICS ANNOUNCES SIX ABSTRACTS ACCEPTED FOR PRESENTATION AT AACR ANNUAL MEETING 2025

25-04-2025
CAMBRIDGE, MASS. & MONTREAL--(BUSINESS WIRE)--REPARE THERAPEUTICS INC. (“REPARE” OR THE “COMPA...
Více zde

REPARE THERAPEUTICS ANNOUNCES LEADERSHIP TRANSITIONS

31-03-2025
CAMBRIDGE, MASS. & MONTREAL--(BUSINESS WIRE)--REPARE THERAPEUTICS INC. (“REPARE” OR THE “COMPA...
Více zde

REPARE REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

07-03-2025
CAMBRIDGE, MASS. & MONTREAL--(BUSINESS WIRE)--REPARE REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING ...
Více zde

REPARE THERAPEUTICS PROVIDES BUSINESS AND CLINICAL UPDATE AND REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS

03-03-2025
CAMBRIDGE, MASS. & MONTREAL--(BUSINESS WIRE)--REPARE THERAPEUTICS PROVIDES BUSINESS AND CLINICAL UPD...
Více zde

REPARE THERAPEUTICS ANNOUNCES PORTFOLIO RE-PRIORITIZATION, PARTNERING INITIATIVES AND COST REDUCTIONS

09-01-2025
CAMBRIDGE, MASS. & MONTREAL--(BUSINESS WIRE)--REPARE THERAPEUTICS ANNOUNCES PORTFOLIO RE-PRIORITIZAT...
Více zde

REPARE THERAPEUTICS ANNOUNCES POSITIVE RESULTS OF THE LUNRESERTIB AND CAMONSERTIB COMBINATION FROM THE MYTHIC PHASE 1 GYNECOLOGIC EXPANSION CLINICAL TRIAL

12-12-2024
CAMBRIDGE, MASS. & MONTREAL--(BUSINESS WIRE)--REPARE THERAPEUTICS ANNOUNCES POSITIVE RESULTS OF THE ...
Více zde

REPARE THERAPEUTICS TO HOST WEBCAST TO REPORT DATA FROM THE LUNRESERTIB AND CAMONSERTIB COMBINATION PHASE 1 MYTHIC CLINICAL TRIAL

10-12-2024
CAMBRIDGE, MASS. & MONTREAL--(BUSINESS WIRE)--REPARE THERAPEUTICS TO HOST WEBCAST TO REPORT DATA FRO...
Více zde

REPARE THERAPEUTICS ANNOUNCES AGREEMENT WITH THE US NATIONAL CANCER INSTITUTE TO ADVANCE THE DEVELOPMENT OF CAMONSERTIB

12-11-2024
CAMBRIDGE, MASS. & MONTREAL--(BUSINESS WIRE)--REPARE THERAPEUTICS ANNOUNCES AGREEMENT WITH THE US NA...
Více zde

REPARE THERAPEUTICS PROVIDES BUSINESS AND CLINICAL UPDATE AND REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS

07-11-2024
CAMBRIDGE, MASS. & MONTREAL--(BUSINESS WIRE)--REPARE THERAPEUTICS PROVIDES BUSINESS AND CLINICAL UPD...
Více zde

REPARE THERAPEUTICS ANNOUNCES UPDATED POSITIVE SAFETY AND TOLERABILITY RESULTS FROM THE PHASE 1 MYTHIC CLINICAL TRIAL

23-10-2024
CAMBRIDGE, MASS. & MONTREAL--(BUSINESS WIRE)--REPARE THERAPEUTICS ANNOUNCES UPDATED POSITIVE SAFETY ...
Více zde

REPARE THERAPEUTICS DOSES FIRST PATIENT IN PHASE 1 CLINICAL TRIAL OF RP-3467, A POLΘ ATPASE INHIBITOR

14-10-2024
CAMBRIDGE, MASS. & MONTREAL--(BUSINESS WIRE)--REPARE THERAPEUTICS DOSES FIRST PATIENT IN PHASE 1 CLI...
Více zde

REPARE THERAPEUTICS ANNOUNCES PHASE 1 DATA HIGHLIGHTING CAMONSERTIB IN COMBINATION WITH RADIOTHERAPY TREATMENT PRESENTED AT THE ASTRO ANNUAL MEETING

30-09-2024
CAMBRIDGE, MASS. & MONTREAL--(BUSINESS WIRE)--REPARE THERAPEUTICS ANNOUNCES PHASE 1 DATA HIGHLIGHTIN...
Více zde

REPARE THERAPEUTICS ANNOUNCES NEW DATA UNDERSCORING NEED FOR ADDITIONAL TREATMENT SOLUTIONS FOR PATIENTS WITH METASTATIC GYNECOLOGIC CANCERS

23-09-2024
CAMBRIDGE, MASS. & MONTREAL--(BUSINESS WIRE)--REPARE THERAPEUTICS ANNOUNCES NEW DATA UNDERSCORING NE...
Více zde

REPARE THERAPEUTICS ANNOUNCES STRATEGIC REPRIORITIZATION TO FOCUS ON BROAD CLINICAL PORTFOLIO

28-08-2024
CAMBRIDGE, MASS. & MONTREAL--(BUSINESS WIRE)--REPARE THERAPEUTICS ANNOUNCES STRATEGIC REPRIORITIZATI...
Více zde

REPARE THERAPEUTICS ANNOUNCES POSITIVE INITIAL DATA AT ESMO GI FROM PHASE 1 MINOTAUR TRIAL EVALUATING LUNRESERTIB IN COMBINATION WITH FOLFIRI

26-06-2024
CAMBRIDGE, MASS. & MONTREAL--(BUSINESS WIRE)--REPARE THERAPEUTICS ANNOUNCES POSITIVE INITIAL DATA AT...
Více zde

FOUNDATION MEDICINE ANNOUNCES PARTNERSHIP WITH REPARE THERAPEUTICS TO PROVIDE GENOMIC PROFILING SERVICES TO SUPPORT CLINICAL TRIALS AND TO DEVELOP COMPANION DIAGNOSTIC FOR LUNRESERTIB

12-06-2024
BOSTON--(BUSINESS WIRE)--FOUNDATION MEDICINE ANNOUNCES A COLLABORATION WITH REPARE THERAPEUTICS TO P...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-28 00:00:008-KStáhnout
2026-01-16 00:00:008-KStáhnout
2025-12-29 00:00:008-KStáhnout
2025-12-19 00:00:008-KStáhnout
2025-11-17 00:00:008-KStáhnout
2025-11-14 00:00:008-KStáhnout
2025-11-14 00:00:0010-QStáhnout
2025-10-22 01:00:008-KStáhnout
2025-10-22 00:00:008-KStáhnout
2025-08-08 01:00:008-KStáhnout
2025-08-08 01:00:0010-QStáhnout
2025-08-08 00:00:008-KStáhnout
2025-08-08 00:00:0010-QStáhnout
2025-07-16 01:00:008-KStáhnout
2025-07-16 00:00:008-KStáhnout
2025-06-20 01:00:008-KStáhnout
2025-06-20 00:00:008-KStáhnout
2025-06-17 01:00:008-KStáhnout
2025-06-17 00:00:008-KStáhnout
2025-05-13 01:00:008-KStáhnout
2025-05-13 01:00:0010-QStáhnout
2025-05-13 00:00:008-KStáhnout
2025-05-13 00:00:0010-QStáhnout
2025-05-01 01:00:008-KStáhnout
2025-05-01 00:00:008-KStáhnout
2025-03-31 01:00:008-KStáhnout
2025-03-31 00:00:008-KStáhnout
2025-03-03 00:00:008-KStáhnout
2025-03-03 00:00:0010-KStáhnout
2025-03-02 23:00:008-KStáhnout
2025-03-02 23:00:0010-KStáhnout
2025-02-25 00:00:008-KStáhnout
2025-02-24 23:00:008-KStáhnout
2025-01-10 00:00:008-KStáhnout
2025-01-09 23:00:008-KStáhnout
2024-12-12 00:00:008-KStáhnout
2024-12-11 23:00:008-KStáhnout
2024-11-07 00:00:008-KStáhnout
2024-11-07 00:00:0010-QStáhnout
2024-11-06 23:00:008-KStáhnout
2024-11-06 23:00:0010-QStáhnout
2024-08-28 01:00:008-KStáhnout
2024-08-28 00:00:008-KStáhnout
2024-08-07 01:00:008-KStáhnout
2024-08-07 00:00:008-KStáhnout
2024-08-06 01:00:008-KStáhnout
2024-08-06 01:00:0010-QStáhnout
2024-08-06 00:00:008-KStáhnout
2024-08-06 00:00:0010-QStáhnout
2024-06-17 01:00:008-KStáhnout
2024-06-17 00:00:008-KStáhnout
2024-05-07 01:00:008-KStáhnout
2024-05-07 01:00:0010-QStáhnout
2024-05-07 00:00:008-KStáhnout
2024-05-07 00:00:0010-QStáhnout
2024-04-26 01:00:008-KStáhnout
2024-04-26 00:00:008-KStáhnout
2024-02-28 00:00:008-KStáhnout
2024-02-28 00:00:0010-KStáhnout
2024-02-27 23:00:008-KStáhnout
2024-02-27 23:00:0010-KStáhnout
2024-02-12 00:00:008-KStáhnout
2024-02-11 23:00:008-KStáhnout
2024-01-25 00:00:008-KStáhnout
2024-01-24 23:00:008-KStáhnout
2024-01-12 00:00:008-KStáhnout
2024-01-11 23:00:008-KStáhnout
2023-11-15 00:00:008-KStáhnout
2023-11-14 23:00:008-KStáhnout
2023-11-09 00:00:008-KStáhnout
2023-11-09 00:00:0010-QStáhnout
2023-11-08 23:00:008-KStáhnout
2023-11-08 23:00:0010-QStáhnout
2023-10-13 01:00:008-KStáhnout
2023-10-13 00:00:008-KStáhnout
2023-10-06 01:00:008-KStáhnout
2023-10-06 00:00:008-KStáhnout
2023-08-09 01:00:008-KStáhnout
2023-08-09 01:00:0010-QStáhnout
2023-08-09 00:00:008-KStáhnout
2023-08-09 00:00:0010-QStáhnout
2023-06-09 01:00:008-KStáhnout
2023-06-09 00:00:008-KStáhnout
2023-06-07 01:00:008-KStáhnout
2023-06-07 00:00:008-KStáhnout
2023-05-09 01:00:008-KStáhnout
2023-05-09 01:00:0010-QStáhnout
2023-05-09 00:00:008-KStáhnout
2023-05-09 00:00:0010-QStáhnout
2023-04-28 01:00:008-KStáhnout
2023-04-28 00:00:008-KStáhnout
2023-04-18 01:00:008-KStáhnout
2023-04-18 00:00:008-KStáhnout
2023-03-10 00:00:008-KStáhnout
2023-03-09 23:00:008-KStáhnout
2023-02-28 00:00:008-KStáhnout
2023-02-28 00:00:0010-KStáhnout
2023-02-27 23:00:008-KStáhnout
2023-02-27 23:00:0010-KStáhnout
2022-11-09 00:00:008-KStáhnout
2022-11-09 00:00:0010-QStáhnout
2022-11-08 23:00:008-KStáhnout
2022-11-08 23:00:0010-QStáhnout
2022-08-04 01:00:008-KStáhnout
2022-08-04 01:00:0010-QStáhnout
2022-08-04 00:00:008-KStáhnout
2022-08-04 00:00:0010-QStáhnout
2022-06-01 01:00:008-KStáhnout
2022-06-01 00:00:008-KStáhnout
2022-05-16 01:00:008-KStáhnout
2022-05-16 00:00:008-KStáhnout
2022-05-05 01:00:008-KStáhnout
2022-05-05 01:00:0010-QStáhnout
2022-05-05 00:00:008-KStáhnout
2022-05-05 00:00:0010-QStáhnout
2022-03-01 00:00:008-KStáhnout
2022-03-01 00:00:0010-KStáhnout
2022-02-28 23:00:008-KStáhnout
2022-02-28 23:00:0010-KStáhnout
2022-01-10 00:00:008-KStáhnout
2022-01-09 23:00:008-KStáhnout
2022-01-07 00:00:008-KStáhnout
2022-01-06 23:00:008-KStáhnout
2021-11-10 00:00:008-KStáhnout
2021-11-10 00:00:0010-QStáhnout
2021-11-09 23:00:008-KStáhnout
2021-11-09 23:00:0010-QStáhnout
2021-11-01 00:00:008-KStáhnout
2021-10-31 23:00:008-KStáhnout
2021-10-08 01:00:008-KStáhnout
2021-10-08 00:00:008-KStáhnout
2021-09-08 01:00:008-KStáhnout
2021-09-08 00:00:008-KStáhnout
2021-08-12 01:00:008-KStáhnout
2021-08-12 01:00:0010-QStáhnout
2021-08-12 00:00:008-KStáhnout
2021-08-12 00:00:0010-QStáhnout
2021-05-14 01:00:008-KStáhnout
2021-05-14 00:00:008-KStáhnout
2021-05-13 01:00:008-KStáhnout
2021-05-13 01:00:0010-QStáhnout
2021-05-13 00:00:008-KStáhnout
2021-05-13 00:00:0010-QStáhnout
2021-04-08 01:00:008-KStáhnout
2021-04-08 00:00:008-KStáhnout
2021-03-04 00:00:008-KStáhnout
2021-03-04 00:00:0010-KStáhnout
2021-03-03 23:00:008-KStáhnout
2021-03-03 23:00:0010-KStáhnout
2020-11-12 00:00:008-KStáhnout
2020-11-12 00:00:0010-QStáhnout
2020-11-11 23:00:008-KStáhnout
2020-11-11 23:00:0010-QStáhnout
2020-08-13 01:00:008-KStáhnout
2020-08-13 01:00:0010-QStáhnout
2020-08-13 00:00:008-KStáhnout
2020-08-13 00:00:0010-QStáhnout
2020-06-23 01:00:008-KStáhnout
2020-06-23 00:00:008-KStáhnout
preloader